Keith Lomas

Keith is a seasoned technology investor with a focus on commercializing novel and patented ideas. Following a successful bond trading career in the City of London, Keith spent over 20 years as CEO of UltraVision CLPL, a leading medical devices group, completing a highly successful trade sale exit in 2018. Keith also has significant experience as a non-executive director and investor in numerous private and public companies; from start up to IPO and exits.